Using social media to help reduce suicide risk among servicemembers
Analysis of a Peer-to-Peer Support Social Media Platform for Service Members and Veterans of the U.S. Military: Intervention 1 (Peer Support)
This study tests a new way to use social media to help U.S. servicemembers and veterans support each other and reduce the risk of suicide.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Harvard University Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06114875 on ClinicalTrials.gov |
What this trial studies
This clinical trial tests a peer support intervention on the social media platform RallyPoint, aimed at reducing suicide risk among U.S. servicemembers and veterans. The study utilizes a machine learning algorithm to identify posts indicating distress, such as suicidal thoughts, and prompts peers to respond with supportive information. By leveraging technology and peer interactions, the trial seeks to provide mental health support outside traditional healthcare settings, addressing barriers to treatment faced by military personnel. The intervention aims to enhance peer engagement and support for those at risk of suicide.
Who should consider this trial
Good fit: Ideal candidates for this study are active users of the RallyPoint social media platform who are either current servicemembers or veterans.
Not a fit: Patients who are not active users of the RallyPoint platform will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve mental health outcomes and reduce suicide rates among servicemembers and veterans.
How similar studies have performed: Other studies have shown promise in using peer support and technology to address mental health issues, indicating potential for success in this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals who are active users on the social media site RallyPoint. Exclusion Criteria: * Individuals who are not active users on the social media site RallyPoint.
Where this trial is running
Boston, Massachusetts
- RallyPoint Networks, Inc — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Study coordinator: Kelly Zuromski, Ph.D.
- Email: kelly_zuromski@fas.harvard.edu
- Phone: 617-475-0595
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.